Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-072833
Filing Date
2025-05-15
Accepted
2025-05-15 17:05:48
Documents
52
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q hcwb-20250331.htm   iXBRL 10-Q 1536209
2 EX-10.4 hcwb-ex10_4.htm EX-10.4 44710
3 EX-10.5 hcwb-ex10_5.htm EX-10.5 25406
4 EX-10.6 hcwb-ex10_6.htm EX-10.6 50997
5 EX-31.1 hcwb-ex31_1.htm EX-31.1 16241
6 EX-31.2 hcwb-ex31_2.htm EX-31.2 16119
7 EX-32.1 hcwb-ex32_1.htm EX-32.1 11206
8 EX-32.2 hcwb-ex32_2.htm EX-32.2 10941
  Complete submission text file 0000950170-25-072833.txt   6139559

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hcwb-20250331.xsd EX-101.SCH 850817
55 EXTRACTED XBRL INSTANCE DOCUMENT hcwb-20250331_htm.xml XML 849083
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Filer) CIK: 0001828673 (see all company filings)

EIN.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40591 | Film No.: 25955218
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)